首页|期刊导航|新中医|基于网络药理学和分子动力学模拟分析柴胡疏肝散治疗甲状腺功能亢进症伴失眠作用机制

基于网络药理学和分子动力学模拟分析柴胡疏肝散治疗甲状腺功能亢进症伴失眠作用机制OA

Analysis of Mechanism of Chaihu Shugan Powder for Hyperthyroidism Complicated by Insomnia Based on Network Pharmacology and Molecular Dynamics Simulation

中文摘要英文摘要

目的:基于网络药理学和分子动力学模拟分析柴胡疏肝散治疗甲状腺功能亢进症伴失眠的作用机制.方法:通过中药系统药理学数据库及分析平台(TCMSP)、Swiss Target Prediction平台筛选柴胡疏肝散的主要化学成分及作用靶点;采用多种数据库预测甲状腺功能亢进症和失眠的相关疾病靶点,与柴胡疏肝散作用靶点取交集;通过STRING平台完成交集靶点蛋白质相互作用(PPI)网络的构建;通过Metascape平台对交集靶点进行基因本体(GO)功能注释和京都基因与基因组百科全书(KEGG)通路富集分析;选取度值排名前5位的核心靶点和核心活性成分,使用Discovery Studio 2019软件对配体和受体进行分子对接,并将结果可视化;使用Gromacs2022进行分子动力学模拟,以评估核心活性成分和关键靶点之间相互作用的稳定性.结果:共筛选柴胡疏肝散活性成分132种,对应靶点883个,甲状腺功能亢进症靶点1 331个,失眠靶点2 361个,药物疾病交集靶点62个.柴胡疏肝散治疗甲状腺功能亢进症伴失眠的主要活性成分为槲皮素、异鼠李素、柚皮素、谷甾醇、甘草吡喃香豆素等,核心靶点主要包括丝氨酸/苏氨酸-蛋白激酶1(AKT1)、白细胞介素(IL)-6、肿瘤坏死因子(TNF)、B淋巴细胞瘤-2(BCL2)、白蛋白(ALB).GO功能分析显示生物过程主要富集于对激素刺激的应答等过程,细胞成分集中在膜侧等功能位置,分子功能涉及信号受体调节活性等功能.KEGG主要富集在晚期糖基化终末产物及其受体(AGE-RAGE)、磷脂酰肌醇3激酶-蛋白激酶B(PI3K-AKT)、Janus激酶-信号转导及转录激活因子(JAK-STAT)等信号通路.分子对接结果发现主要活性成分与关键靶点能够较好结合,分子动力学模拟进一步验证了AKT1-槲皮素、ALB-异鼠李素复合体的稳定性.结论:网络药理学分析结果显示,柴胡疏肝散通过槲皮素、异鼠李素、柚皮素、谷甾醇及甘草吡喃香豆素等成分,作用于AKT1、IL-6、TNF、BCL2、ALB等靶点,调控AGE-RAGE、PI3K-AKT、JAK-STAT等信号通路治疗甲状腺功能亢进症伴失眠.

Objective:To analyze the action mechanism of Chaihu Shugan Powder in treating hyperthyroidism complicated by insomnia by integrating network pharmacology and molecular dynamics simulation.Methods:The main chemical components and their corresponding targets of Chaihu Shugan Powder were screened using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP)and the Swiss Target Prediction platform.Disease-related targets for hyperthyroidism and insomnia were retrieved from multiple databases,and the intersection with the targets of Chaihu Shugan Powder was obtained.The STRING database was used to construct the protein-protein interaction(PPI)network of the intersecting targets.Gene Ontology(GO)functional annotation and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analyses of the intersecting targets were performed via the Metascape platform.The top five core targets and core active components(ranked by degree value)were selected for molecular docking between ligands and receptors using Discovery Studio 2019 software,and the results were visualized.Gromacs 2022 was used for molecular dynamics simulation to evaluate the stability of interactions between core active components and key targets.Results:A total of 132 active components of Chaihu Shugan Powder were screened,corresponding to 883 targets,along with 1 331 targets related to hyperthyroidism and 2 361 targets related to insomnia.The intersecting targets between the drug and the diseases amounted to 62.The core components of Chaihu Shugan Powder for treating this disease included quercetin,isorhamnetin,naringenin,sitosterol,and licopyranocoumarin,etc.The core targets mainly included AKT serine/threonine-protein kinase 1(AKT1),interleukin(IL)-6,tumor necrosis factor(TNF),B-cell lymphoma-2(BCL2),and albumin(ALB).GO functional analysis showed that the biological processes were mainly enriched in responses to hormonal stimuli and other processes,the cellular components were concentrated in functional locations such as the membrane side,and the molecular functions involved signal receptor regulatory activity and other functions.KEGG pathway enrichment analysis mainly focused on signaling pathways including advanced glycation end-products and receptor for advanced glycation end products(AGE-RAGE),phosphatidylinositol 3-kinase-protein kinase B(PI3K-AKT),and Janus kinase-signal transducer and activator of transcription(JAK-STAT).Molecular docking results showed that core active components could bind well to key targets,and molecular dynamics simulation further verified the stability of the AKT1-quercetin and ALB-isorhamnetin complexes.Conclusion:Network pharmacology analysis suggests that Chaihu Shugan Powder exerts therapeutic effects on hyperthyroidism complicated by insomnia through components such as quercetin,isorhamnetin,naringenin,sitosterol,and licopyranocoumarin,acting on targets including AKT1,IL-6,TNF,BCL2,and ALB,and regulating signaling pathways such as AGE-RAGE,PI3K-AKT,and JAK-STAT.

程学涛;曾韦维;孙顺;张宏武

广州中医药大学深圳中西医结合临床医学院,广东 深圳 518104广州中医药大学深圳中西医结合临床医学院,广东 深圳 518104暨南大学南海中医院,广东 佛山 528200深圳市中西医结合医院,广东 深圳 518104

医药卫生

甲状腺功能亢进症失眠柴胡疏肝散网络药理学分子对接分子动力学模拟作用机制

HyperthyroidismInsomniaChaihu Shugan PowderNetwork pharmacologyMolecular dockingMolecular dynamics simulationMechanism of action

《新中医》 2026 (3)

160-169,10

2024年深圳市宝安区医疗卫生科研项目(2024JD284)

10.13457/j.cnki.jncm.2026.03.027

评论